{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:07Z","timestamp":1793642347297,"version":"4.5.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The prevalence of cardiac syndrome X (CSX) is considerable. Some patients show recurrent angina attacks and have a poor prognosis. However, the knowledge of CSX pathophysiological mechanism is still limited, and the treatment fails to achieve a satisfactory suppression of symptoms. Nicorandil has a beneficial effect on improving coronary microvascular dysfunction (CMD). This study aims to evaluate the clinical effects and safety of nicorandil on CSX patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The Cochrane Library, Pubmed, EMBASE, ClinicalTrials.gov and 4 Chinese databases were searched to identify relevant studies. The Cochrane \u201cRisk of bias\u201d tool was used to assess the methodological quality of eligible studies. Meta-analysis was performed by RevMan 5.3 software. The Eggers test and meta-regression were performed by software Stata 14.0. Quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty four randomized controlled trials (RCTs) involving 2323 patients were included. Most of the included studies were classified as having an unclear risk of bias because of poor reported methodology. The main outcomes are angina symptoms improvement, resting electrocardiogram (ECG) improvement, treadmill test result, and endothelial function. Meta-analysis showed that nicorandil had some benefit on improving angina symptoms (RR 1.24, 95% CI 1.19 to 1.29,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a20%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a&lt;\u200a.00001), resting ECG (RR\u200a=\u200a1.24, 95% IC: 1.15 to 1.33,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a&lt;\u200a.00001), and prolonged the time to 1\u200amm ST-segment depression in treadmill test result (WMD\u200a=\u200a38.41, 95% IC: 18.46 to 58.36,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.0002). Besides nicorandil could reduce the level of endothelin-1 (ET-1) (SMD\u200a=\u200a\u22122.22, 95% IC: \u22122.61 to \u22121.83,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a77%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a&lt;\u200a.00001) and increase the level of nitric oxide (NO) (WMD\u200a=\u200a27.45, 95% IC: 125.65 to 29.24,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a81%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a&lt;\u200a.00001). No serious adverse drug event was reported. The Eggers test showed that significant statistical publication bias was detected (Eggers test\n                      <jats:italic toggle=\"yes\">P\u200a<\/jats:italic>\n                      =\u200a.000). The quality of evidence ranged from very low to low.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Nicorandil shows the potential of improving angina symptoms, ECG, and endothelial dysfunction in patients with CSX. However, there is insufficient evidence for the clinical benefits of nicorandil due to the very low-quality evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000022167","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T02:04:36Z","timestamp":1599703476000},"page":"e22167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["The effect of nicorandil in patients with cardiac syndrome X"],"prefix":"10.1097","volume":"99","author":[{"given":"Qiulei","family":"Jia","sequence":"first","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"},{"name":"Graduate School, Beijing University of Chinese Medicine, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"},{"name":"Graduate School, Beijing University of Chinese Medicine, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"R1-20251104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.hfc.2015.08.012","article-title":"Cardiac syndrome X: update","volume":"12","author":"Agrawal","year":"2016","journal-title":"Heart Fail Clin"},{"key":"R2-20251104","first-page":"457","article-title":"Angina pectoris and normal coronary arteries: cardiac syndrome X","volume":"90","author":"Crea","year":"2004","journal-title":"Heart (British Cardiac Society)"},{"key":"R3-20251104","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ahj.2014.03.001","article-title":"Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice","volume":"167","author":"Patel","year":"2014","journal-title":"Am Heart J"},{"key":"R4-20251104","first-page":"437","article-title":"Cardiac syndrome X: an important cause of microvascular angina","volume":"46","author":"Kanar","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R5-20251104","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R6-20251104","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0735-1097(94)00507-M","article-title":"Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study","volume":"25","author":"Kaski","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R7-20251104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1253\/jcj.58.43","article-title":"Excellent prognosis of Japanese patients with chest pain and normal or nearly normal coronary arteries--2- to 13-year follow-up of 274 patients after coronary cineangiography","volume":"58","author":"Hirota","year":"1994","journal-title":"Jpn Circ J"},{"key":"R8-20251104","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"R9-20251104","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"key":"R10-20251104","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"R11-20251104","first-page":"419","article-title":"Assessment of the left ventricular systolic function in cardiac syndrome X using speckle tracking echocardiography","volume":"16","author":"Ya\u011fmur","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"R12-20251104","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10554-016-1053-3","article-title":"Value of three-dimensional strain parameters for predicting left ventricular remodeling after ST-elevation myocardial infarction","volume":"33","author":"Xu","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"R13-20251104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000495109","article-title":"Level of Anxiety and Depression in Cardiac Syndrome X","volume":"28","author":"Cekirdekci","year":"2019","journal-title":"Med Princ Pract"},{"key":"R14-20251104","doi-asserted-by":"crossref","first-page":"e93170","DOI":"10.1371\/journal.pone.0093170","article-title":"Burden of hospital admission and repeat angiography in angina pectoris patients with and without coronary artery disease: a registry-based cohort study","volume":"9","author":"Jespersen","year":"2014","journal-title":"PloS One"},{"key":"R15-20251104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11936-018-0667-2","article-title":"Cardiac rehabilitation and exercise prescription in symptomatic patients with non-obstructive coronary artery disease-a systematic review","volume":"20","author":"Kissel","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"R16-20251104","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"R17-20251104","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R18-20251104","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/eurheartj\/ehr009","article-title":"Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain?","volume":"32","author":"Johnston","year":"2011","journal-title":"Eur Heart J"},{"key":"R19-20251104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"R20-20251104","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"R21-20251104","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-016-6668-z","article-title":"Vasodilator therapy: nitrates and nicorandil","volume":"30","author":"Tarkin","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"R22-20251104","first-page":"421","article-title":"Chinese expert consensus guidelines for diagnosis and management of coronary microvascular disease","volume":"32","author":"Zhang","year":"2017","journal-title":"Chin Circ J"},{"key":"R23-20251104","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF00879868","article-title":"Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms","volume":"9","author":"Yamabe","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"R24-20251104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9149(97)00279-8","article-title":"Effects of short-term treatment of Nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina","volume":"80","author":"Chen","year":"1997","journal-title":"Am J Cardiol"},{"key":"R25-20251104","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"key":"R26-20251104","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","article-title":"AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews","volume":"62","author":"Shea","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R28-20251104","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R29-20251104","first-page":"572","article-title":"Anti-anginal effect of nicorandil versus nitrates in patients with microvascular angina","volume":"32","author":"Oraby","year":"2011","journal-title":"Eur Heart J"},{"key":"R30-20251104","first-page":"807","article-title":"Clinical efficacy of nicorandil in the treatment of microvascular angina and its effect on vascular endothelial function","volume":"25","author":"Cen","year":"2014","journal-title":"Hainan Med J"},{"key":"R31-20251104","first-page":"296","article-title":"Influence of nicorandil on levels of hsCRP,sCD40L and therapeutic effect of nicorandil in patients with microvascular angina pectoris","volume":"27","author":"Chen","year":"2018","journal-title":"Chin J Cardiovasc Rehab Med"},{"key":"R32-20251104","first-page":"143","article-title":"Clinical efficacy of nicorandil in the treatment of microvascular angina","volume":"6","author":"Chen","year":"2016","journal-title":"J Front Med"},{"key":"R33-20251104","first-page":"250","article-title":"Effect observation of nicorandil in treatment of microvascular angina","volume":"8","author":"Cui","year":"2018","journal-title":"China Med Pharmacy"},{"key":"R34-20251104","first-page":"322","article-title":"The effect of nicorandil on stable microvascular angina","author":"Gao","year":"2016","journal-title":"Acta Academiae Medicinae Qingdao Universitatis"},{"key":"R36-20251104","first-page":"2134","article-title":"Clinical efficacy of nicorandil in the treatment of microvascular angina and its effect on vascular endothelial","volume":"24","author":"He","year":"2015","journal-title":"Modern J Integr Tradit Chin West Med"},{"key":"R37-20251104","first-page":"676","article-title":"Efficacy of nicorandil for treating the patients with cardiac syndrome X and its impact on vascular endothelial function","volume":"32","author":"He","year":"2017","journal-title":"Chin Circ J"},{"key":"R38-20251104","first-page":"151","article-title":"Efficacy and the incidence of adverse reactions of nicorandil on stable microvascular angina","volume":"31","author":"Hong","year":"2019","journal-title":"Strait Pharmaceut J"},{"key":"R39-20251104","first-page":"131","article-title":"Clinical efficacy of nicorandil in the treatment of microvascular angina and its effect on vascular endothelial","author":"Jin","year":"2016","journal-title":"Contemp Med"},{"key":"R40-20251104","first-page":"149","article-title":"Comparison of the effect of nicorandil and trimetazidine on microvascular angina","author":"Jin","year":"2016","journal-title":"J Med Forum"},{"key":"R41-20251104","first-page":"28","article-title":"The effect of nicorandil on the treatment of microvascular angina pectoris and the improvement of vascular endothelial function","volume":"39","author":"Liu","year":"2018","journal-title":"Foreign Med Sci (Section of Medgeography)"},{"key":"R42-20251104","first-page":"64","article-title":"Effect of nicorandil on cardiac syndrome X","author":"Lv","year":"2016","journal-title":"Chin Heart J"},{"key":"R43-20251104","first-page":"77","article-title":"Analysis of therapeutic effect of nicorandil on stable microvascular angina","volume":"12","author":"Quan","year":"2018","journal-title":"Chin J Modern Drug Appl"},{"key":"R44-20251104","first-page":"41","article-title":"Comparison of the effect of nicorandil and trimetazidine on microvascular angina","volume":"4","author":"Wang","year":"2016","journal-title":"Cardiovasc Dis J Integr Tradit Chin Western Med (Electronic)"},{"key":"R45-20251104","first-page":"127","article-title":"Efficacy of nicorandil for treating the patients with stable microvascular angina","volume":"33","author":"Xu","year":"2017","journal-title":"Gansu Sci Technol"},{"key":"R46-20251104","first-page":"3315","article-title":"Effect observation of nicorandil in treatment of microvascular angina","volume":"29","author":"Yan","year":"2018","journal-title":"Modern Diagn Treat"},{"key":"R47-20251104","first-page":"4003","article-title":"Comparison of the effect of nicorandil and trimetazidine in X-syndrome patients","volume":"19","author":"Yin","year":"2013","journal-title":"Med Recap"},{"key":"R48-20251104","first-page":"17","article-title":"Clinical effect, safety and compliance of nicorandil in treatment of microvascular angina","volume":"14","author":"Zhang","year":"2017","journal-title":"China Licens Pharmacist"},{"key":"R49-20251104","first-page":"763","article-title":"Comparison of therapeutic effect between Nicorandil and isosorbide mononitrate tablets in treatment of microvascular angina","volume":"28","author":"Zhou","year":"2012","journal-title":"Occupation Health"},{"key":"R50-20251104","first-page":"44","article-title":"Efficacy of nicorandil for treating the patients with microvascular angina","volume":"12","author":"He","year":"2019","journal-title":"Chin J Clin Rational Drug Use"},{"key":"R51-20251104","first-page":"112","article-title":"Clinical efficacy of nicorandil in the treatment of microvascular angina","volume":"15","author":"Ji","year":"2020","journal-title":"China Pract Med"},{"key":"R52-20251104","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"R53-20251104","first-page":"397","article-title":"Association of inflammation and endothelial dysfunction with coronary microvascular resistance in patients with cardiac syndrome X","volume":"109","author":"Long","year":"2017","journal-title":"Arquivos brasileiros de cardiologia"},{"key":"R54-20251104","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R55-20251104","first-page":"478","article-title":"Coronary microcirculatory pathophysiology: can we afford it to remain a black box?","volume":"38","author":"Pries","year":"2017","journal-title":"Eur Heart J"},{"key":"R56-20251104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/org.6.1.10427","article-title":"Microvascular rarefaction: the decline and fall of blood vessels","volume":"6","author":"Goligorsky","year":"2010","journal-title":"Organogenesis"},{"key":"R57-20251104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MCA.0b013e328363258c","article-title":"Evaluation of coronary microvascular function and nitric oxide synthase intron 4a\/b polymorphism in patients with coronary slow flow","volume":"24","author":"Ekmekci","year":"2013","journal-title":"Coron Artery Dis"},{"key":"R58-20251104","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/003655102753517145","article-title":"Biochemical parameters of endothelial dysfunction in cardiological syndrome X","volume":"62","author":"Kolasinska-Kloch","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"R59-20251104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10557-013-6456-y","article-title":"Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study","volume":"27","author":"Ito","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"R60-20251104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12947-015-0020-9","article-title":"The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI","volume":"13","author":"Kostic","year":"2015","journal-title":"Cardiovasc Ultrasound"},{"key":"R61-20251104","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MCA.0000000000000179","article-title":"Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow","volume":"26","author":"Chen","year":"2015","journal-title":"Coron Artery Dis"},{"key":"R62-20251104","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005344-199510000-00006","article-title":"Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels","volume":"26","author":"Akai","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"R63-20251104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0735-1097(99)00539-2","article-title":"Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease","volume":"35","author":"Matsubara","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R64-20251104","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2306\/scienceasia1513-1874.2012.38.136","article-title":"Oxidative stress status in patients with cardiac syndrome X","volume":"38","author":"Seydi-Shirvani","year":"2012","journal-title":"Scienceasia"},{"key":"R65-20251104","first-page":"31","article-title":"Comparison of serum gamma-glutamyltransferase levels between patients with cardiac syndrome X and healthy asymptomatic individuals","volume":"70","author":"Demir","year":"2012","journal-title":"Kardiol Polska"},{"key":"R66-20251104","doi-asserted-by":"crossref","first-page":"75926","DOI":"10.18632\/oncotarget.12444","article-title":"Delayed reendothelialization with rapamycin is rescued by the addition of nicorandil in balloon-injured rat carotid arteries","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"R67-20251104","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1308\/003588412X13171221501573","article-title":"Nicorandil associated anal ulcers: an estimate of incidence","volume":"94","author":"Colvin","year":"2012","journal-title":"Ann R Coll Surg Engl"},{"key":"R68-20251104","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2230.2010.03932.x","article-title":"Nicorandil-induced leg ulceration without mucosal involvement","volume":"36","author":"Mikeljevic","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"R69-20251104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1472-6882-13-62","article-title":"Potential effectiveness of traditional Chinese medicine for cardiac syndrome X (CSX): a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"R70-20251104","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11655-017-2762-8","article-title":"Tongxinluo capsule() for cardiac syndrome X: a systematic review and meta-analysis","volume":"24","author":"Mao","year":"2018","journal-title":"Chin J Integr Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:01:13Z","timestamp":1762243273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022167"}},"subtitle":["A meta-analysis of randomized controlled trials"],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":68,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022167","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"2020-03-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}